剖宫产瘢痕处妊娠患者采用高强度聚焦超声消融治疗的临床疗效及安全性评价

剖宫产瘢痕处妊娠患者采用高强度聚焦超声消融治疗的临床疗效及安全性评价

ID:23935910

大小:804.95 KB

页数:33页

时间:2018-11-11

剖宫产瘢痕处妊娠患者采用高强度聚焦超声消融治疗的临床疗效及安全性评价_第1页
剖宫产瘢痕处妊娠患者采用高强度聚焦超声消融治疗的临床疗效及安全性评价_第2页
剖宫产瘢痕处妊娠患者采用高强度聚焦超声消融治疗的临床疗效及安全性评价_第3页
剖宫产瘢痕处妊娠患者采用高强度聚焦超声消融治疗的临床疗效及安全性评价_第4页
剖宫产瘢痕处妊娠患者采用高强度聚焦超声消融治疗的临床疗效及安全性评价_第5页
资源描述:

《剖宫产瘢痕处妊娠患者采用高强度聚焦超声消融治疗的临床疗效及安全性评价》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、授予单位代码10089学号或申请号16022中国图书分类号R711.74HebeiMedicalUniversity硕士学位论文学术学位剖宫产瘢痕处妊娠患者采用高强度聚焦超声消融治疗的临床疗效及安全性评价研究生:镡丽霞导师:郭清教授专业:妇产科学二级学院:石家庄市第一医院2018年3月目录中文摘要·······································································································1英文摘要····································

2、···································································4英文缩写·······································································································7研究论文剖宫产瘢痕处妊娠患者采用高强度聚焦超声消融治疗的临床疗效及安全性评价前言·············································································

3、····························8材料与方法·····················································································8结果·······································································································11讨论································································

4、································14结论··········································································································18参考文献···························································································18综述剖宫产瘢痕处妊娠患者采用高强度聚焦超声消融治疗的临床疗效及安全性评价················

5、···························································22致谢················································································································29个人简历································································································30剖宫产瘢痕处妊娠患者采用高强

6、度聚焦超声消融治疗的的临床疗效及安全性评价摘要目的:探索剖宫产瘢痕处妊娠(cesareanscarpregnancy,CSP)患者采用高强度聚焦超声(HighIntensityFocusedUltrasound,HIFU)消融治疗的临床疗效,并将实施子宫动脉栓塞术(uterinearteryembolization,UAE)和阴式手术治疗的患者分别作为对照组进行研究,比较和分析治疗相关指标和临床疗效和安全性,讨论该治疗方法的临床价值和意义。方法:选取石家庄市第一医院2016年1月至2017年12月期间就诊的CSP患者,根据就诊顺序进行编号,随机分为三组,实验组采用HIFU消融+宫

7、腔镜手术治疗,对照组1采用UAE+宫腔镜手术治疗,对照组2采用阴式CSP病灶切除修补术。观察、记录并比较三组患者基本资料、发病情况、治疗相关指标以及治疗后恢复情况。观察指标:1)记录三组患者平均年龄、孕史、产史和发病距上一次剖宫产手术时间等基本资料;记录三组患者胎囊直径、临床分型情况等病情资料。2)记录三组患者治疗成功率,包括初次治疗成功率以及出现大出血、血清β-HCG值下降不满意、胎囊残留等二次手术治疗成功情况;观察记录三组患者住院天数、治疗费用和疼痛等级评分情况。3)记录三组

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。